Xuezhong Yu to Cell Line, Tumor
This is a "connection" page, showing publications Xuezhong Yu has written about Cell Line, Tumor.
Connection Strength
0.069
-
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
Score: 0.027
-
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Oncotarget. 2015 Dec 01; 6(38):41383-97.
Score: 0.022
-
Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014 Nov 01; 74(21):6048-59.
Score: 0.020